Real-world utilization, safety, and observed clinical outcomes of dapagliflozin among Sudanese patients with heart failure: a multicenter retrospective cohort study
A retrospective study of Sudanese heart failure patients found that the drug dapagliflozin is safe and effective in real-world clinical settings. The research highlights positive improvements in heart function and glycemic control among the study participants.
Why it matters
This study provides evidence that advanced heart failure treatments can be successfully implemented in low-resource healthcare settings.
Scientific Reports ( 2026 ) Cite this article
We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in